Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans.

Pedro Luis EsquinasAjit ShintoKoramadai K KamaleshwaranJephy JosephAnna Celler

Published in: EJNMMI physics (2018)

The large inter-patient variability of the absorbed doses in tumors and normal tissue in 188Re-HDD-Lipiodol radioembolization patients emphasizes the importance of patient-specific dosimetry calculations based on quantitative post-treatment SPECT/CT imaging.

Keyphrases

computed tomography
high resolution
dual energy
newly diagnosed
image quality
ejection fraction
magnetic resonance imaging
pet ct
case report
positron emission tomography
combination therapy
density functional theory
molecular dynamics
monte carlo
mass spectrometry
replacement therapy
smoking cessation